Abstract

Increasing evidence suggests that bromocriptine (2-bromo-alpha-ergocryptine), which can be used to restore normal serum prolactin levels in patients with prolactin-secreting pituitary adenomas, may have a direct antitumor effect on certain pituitary adenomas. We review briefly the medical, endocrinological, and neurosurgical studies reporting the efficacy of bromocriptine in the treatment of pituitary endocrinopathies, as well as studies that suggest an antitumor effect.

Original languageEnglish (US)
Pages (from-to)741-744
Number of pages4
JournalNeurosurgery
Volume8
Issue number6
DOIs
StatePublished - Jan 1 1981

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Bromocriptine treatment of pituitary adenomas'. Together they form a unique fingerprint.

Cite this